These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 8267750)
61. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels. DiMaio MS; Baumgarten A; Greenstein RM; Saal HM; Mahoney MJ N Engl J Med; 1987 Aug; 317(6):342-6. PubMed ID: 2439909 [TBL] [Abstract][Full Text] [Related]
62. Trends in prenatal diagnosis of Down's syndrome. Spencer K BMJ; 1993 Mar; 306(6878):650. PubMed ID: 8357367 [No Abstract] [Full Text] [Related]
63. [Prenatal screening for Down's syndrome]. Qin Q; Christiansen M; Norgaard-Pedersen B Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):694-7. PubMed ID: 9639772 [No Abstract] [Full Text] [Related]
64. Improving methods of screening for Down's syndrome. White I; Papiha SS; Magnay D N Engl J Med; 1989 Feb; 320(6):401-2. PubMed ID: 2464139 [No Abstract] [Full Text] [Related]
66. Antenatal screening for Down's syndrome. Performance of different markers remains confused. Haddow JE; Knight GJ; Palomaki GE BMJ; 1993 Sep; 307(6905):679-80. PubMed ID: 8401065 [No Abstract] [Full Text] [Related]
67. Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies. Gilbert RE; Augood C; Gupta R; Ades AE; Logan S; Sculpher M; van Der Meulen JH BMJ; 2001 Aug; 323(7310):423-5. PubMed ID: 11520837 [TBL] [Abstract][Full Text] [Related]
68. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A. Haddow JE; Palomaki GE; Knight GJ; Foster DL; Neveux LM J Med Screen; 1998; 5(3):115-9. PubMed ID: 9795869 [TBL] [Abstract][Full Text] [Related]
71. [Second trimester maternal serum screening for Down's syndrome in mainland China: a multi-center prospective study]. Bian XM; Liu JT; Qi QW; Jiang YL; Li Y; Liu SY; Hao N; Zhou J; Lü SM; Zhu BS; Wang H; Xu ZF; Pan XY; Liao C; Cai Y; Wang H; Wang Z; Zhu J; Hu YL Zhonghua Fu Chan Ke Za Zhi; 2008 Nov; 43(11):805-9. PubMed ID: 19087560 [TBL] [Abstract][Full Text] [Related]
72. Pre-natal screening for Down's syndrome. Keatinge R; Williams ES J Public Health Med; 1994 Mar; 16(1):115; author reply 116-7. PubMed ID: 8037944 [No Abstract] [Full Text] [Related]
73. [Arguments for offering triple test serum screening for Down's syndrome to all pregnant women]. van der Maas PJ; Dondorp WJ Ned Tijdschr Geneeskd; 2002 Mar; 146(11):501-3. PubMed ID: 11925798 [TBL] [Abstract][Full Text] [Related]
74. Antenatal screening for Down's syndrome: where are we and where next? Haddow JE Lancet; 1998 Aug; 352(9125):336-7. PubMed ID: 9717914 [No Abstract] [Full Text] [Related]
75. Risk assessment adjusted for gestational age in maternal serum screening for Down's syndrome. Gardosi J; Mongelli M BMJ; 1993 Jun; 306(6891):1509-11. PubMed ID: 8518678 [TBL] [Abstract][Full Text] [Related]
77. Antenatal screening for neural tube defects and Down's syndrome--the importance of pretest counselling. Seman E Med J Aust; 1994 May; 160(10):658-60. PubMed ID: 8177121 [No Abstract] [Full Text] [Related]
78. Down's syndrome: current screening techniques. White RS South Med J; 1989 Dec; 82(12):1483-6. PubMed ID: 2480649 [TBL] [Abstract][Full Text] [Related]
79. Serum screening for Down's syndrome: experiences of obstetricians in England and Wales. Green JM BMJ; 1994 Sep; 309(6957):769-72. PubMed ID: 7950560 [TBL] [Abstract][Full Text] [Related]